Pulmonary Hypertension News and Research

RSS
Pulmonary arterial hypertension (PAH) is a condition involving high blood pressure and structural changes in the walls of the pulmonary arteries, which are the blood vessels that connect the right side of the heart to the lungs. Affecting people of all ages and ethnic backgrounds - but most commonly found in young women of child-bearing years - the disease has historically been chronic and incurable, with a poor survival rate. PAH is often not diagnosed in a timely manner because its early symptoms can be confused with those of many other pulmonary and respiratory conditions. Symptoms include shortness of breath, extreme fatigue, dizziness, fainting, swollen ankles and legs and chest pain (especially during physical activity). With proper diagnosis, there are currently several therapies to alleviate symptoms and improve quality of life for PAH patients. The key is to find a PAH specialist and pursue immediate treatment.
Discovery will lead to more effective treatments for pulmonary arterial hypertension

Discovery will lead to more effective treatments for pulmonary arterial hypertension

Female lung transplant recipients more likely to suffer from primary graft dysfunction

Female lung transplant recipients more likely to suffer from primary graft dysfunction

Myogen's Ambrisentan granted orphan drug designation by Europeans

Myogen's Ambrisentan granted orphan drug designation by Europeans

Researchers have identified a new clinical syndrome

Researchers have identified a new clinical syndrome

First evidence that preeclampsia can leave a persistent and potentially fatal imprint in the pulmonary circulation of the fetus

First evidence that preeclampsia can leave a persistent and potentially fatal imprint in the pulmonary circulation of the fetus

Statins, other cholesterol-depleting agents, may disrupt hypertension from developing

Statins, other cholesterol-depleting agents, may disrupt hypertension from developing

Garlic protects against severe chronic pulmonary hypertension

Garlic protects against severe chronic pulmonary hypertension

New understanding of the causes for symptoms of sickle cell disease

New understanding of the causes for symptoms of sickle cell disease

No association between a herpesvirus infection and pulmonary hypertension

No association between a herpesvirus infection and pulmonary hypertension

New advances in sickle cell disease

New advances in sickle cell disease

FDA approves Remodulin for the treatment of pulmonary arterial hypertension

FDA approves Remodulin for the treatment of pulmonary arterial hypertension

Cells linked to asthma and eczema also help cure deadly illness in mice

Cells linked to asthma and eczema also help cure deadly illness in mice

Mast cells can provide protection from a potentially deadly condition known as sepsis

Mast cells can provide protection from a potentially deadly condition known as sepsis

Investigational drug for pulmonary hypertension may improve the quality of life for patients with scleroderma and lupus

Investigational drug for pulmonary hypertension may improve the quality of life for patients with scleroderma and lupus

Inhaled nitrite spray may help babies diagnosed with persistent pulmonary hypertension of the newborn

Inhaled nitrite spray may help babies diagnosed with persistent pulmonary hypertension of the newborn

Two more drugs added to Medicare demonstration program

Two more drugs added to Medicare demonstration program

Blood vessel plug - amplatzer ductal occluder, performs well in trial

Blood vessel plug - amplatzer ductal occluder, performs well in trial

Typical warning signs for sleep apnea

Typical warning signs for sleep apnea

New guidelines for pulmonary arterial hypertension caution the use of calcium channel blockers

New guidelines for pulmonary arterial hypertension caution the use of calcium channel blockers

50,000 people in the U.S. with cancer, multiple sclerosis, rheumatoid arthritis or hepatitis C will be eligible for a Medicare drug lottery

50,000 people in the U.S. with cancer, multiple sclerosis, rheumatoid arthritis or hepatitis C will be eligible for a Medicare drug lottery